Diverse effects of ascorbic acid and palmitoyl ascorbate on Helicobacter pylori survival and growth

FEMS Microbiology Letters

Volumn 224, Issue 2, 2003, Pages 247-253

  Tabak, M ^a   Armon, R ^a   Rosenblat, G ^a   Stermer, E ^b   Neeman, I ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b BNAI ZION MEDICAL CENTER   (Israel)

Author keywords

Ascorbic acid; Growth; Helicobacter pylori; Palmitoyl ascorbate; Survival

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; ASCORBIC ACID DERIVATIVE; PALMITOYL ASCORBATE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

AEROBIC CELL CULTURE; ARTICLE; BACILLUS CEREUS; BACILLUS SUBTILIS; BACTERIAL CELL; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERICIDAL ACTIVITY; CAMPYLOBACTER JEJUNI; CLOSTRIDIUM SPOROGENES; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; GENETIC VARIABILITY; GROWTH INHIBITION; HELICOBACTER PYLORI; HYDROPHOBICITY; NONHUMAN; PRIORITY JOURNAL; PROTEUS MIRABILIS; PROTEUS VULGARIS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STATISTICAL SIGNIFICANCE;

BACILLUS CEREUS; BACILLUS SUBTILIS; BACTERIA (MICROORGANISMS); CAMPYLOBACTER; CAMPYLOBACTER JEJUNI; CLOSTRIDIUM; CLOSTRIDIUM SPOROGENES; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; HELICOBACTER; HELICOBACTER PYLORI; MIRABILIS; PROTEUS MIRABILIS; PROTEUS VULGARIS; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 0042208117     PISSN: 03781097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1097(03)00439-7     Document Type: Article

References (36)

1. Marshall B.J. Treatment strategies for Helicobacter pylori infection. Gastroenterol. Clin. North Am. 22:1993;183-198.
2. th Food Microbiology Symposium 'Current concepts in food borne pathogens and rapid and automated methods in food microbiology', University of Wisconsin, River Falls, WI.
3. Dunn B.E., Cohen H., Blaser M.J. Helicobacter pylori. Clin. Microbiol. Rev. 10:1997;720-741.
4. Czkwianianc E., Bak-Romaniszyn L., Malecka-Panas E., Suski S., Woch G. Prevalence of Helicobacter pylori in children dependent on age and living conditions. J. Physiol. Pharmacol. 47:1996;203-207.
5. Dubois A. Spiral bacteria in the human stomach: the gastric Helicobacters. Emerg. Infect. Dis. 1:1995;79-85.
6. Handt L.K., Fox J.G., Dewhirst F.E., Fraser G.J., Paster B.J., Yan L.L., Rozmiarek H., Rufo R., Stalis I.H. Helicobacter pylori isolated from the domestic cat: public health implications. Infect. Immunol. 62:1994;2367-2374.
7. Goodman K.J., Correa P., Tengana-Aux H.J., Ramirez H., DeLany J.P., Guerrero-Pepinosa O., Lopez-Quiñones M., Collazos-Parra T. Helicobacter pylori infection in the Colombian Andes: a population based study of transmission pathways. Am. J. Epidemiol. 144:1996;290-299.
8. Buiatti E., Palli D., Decarli A., Amadori D., Avellini C., Bianchi S., et al. A case-control study of gastric cancer and diet in Italy. II. Association with nutrients. Int. J. Cancer. 45:1990;896-901.
9. Correa P., Malcolm G., Schmidt B., Fontham E., Ruiz B., Bravo J.C., Bravo L.E., Zarama G., Realpe J.L. Review article: antioxidant micronutrients and gastric cancer. Aliment. Pharmacol. Ther. 12:(Suppl. 1):1998;73-82.
10. Ruiz B., Rood J.C., Fontham E.T.H., Malcolm G.T., Hunter F.M., Sobhan M., Johnson W.D., Correa P. Vitamin C concentration in gastric juice before and after anti-Helicobacter pylori treatment. Am. J. Gastroenterol. 89:1994;533-539.
11. Fraser A.G., Woollard G.A. Helicobacter pylori, peptic ulcer and non-ulcer dyspepsia: gastric juice ascorbic acid is related to Helicobacter pylori infection but not ethnicity. J. Gastroenterol. Hepatol. 14:1999;1070-1073.
12. You W.-C., Zhang L., Gail M.H., Chang Y.-S., Liu W.-D., Ma J.-L., Li J.-Y., Jin M.-L., Hu Y.-R., Yang C.-S., Blaser M.J., Correa P., Blot W.J., Fraumeni J.F., Xu G.-W. Gastric dysplasia and gastric cancer: Helicobacter pylori, serum vitamin C and other risk factors. J. Natl. Cancer Inst. 92:2000;1607-1612.
13. Mirvish S.S. Effects of vitamin C and E on N-nitroso compound formation, carcinogenesis and cancer. Cancer. 58:1986;1842-1850.
14. Zhang H.-M., Wakisaka N., Maeda O., Yamamoto T. Vitamin C inhibits the growth of a bacterial risk factor for gastric carcinoma: Helicobacter pylori. Cancer. 80:1997;1897-1903.
15. Tyrsina E.G., Rossikhina O.G., Abilev S.K., Tyrsin Yu.A. Inhibition of the bacterial mutagenicity of N-methyl-N′-nitro-N-nitrosoguanine by ascorbic acid and ascorbyl palmitate. Mutat. Res. 321:1994;81-87.
16. Giacosa A., Filiberti R. Free radicals, oxidative damage and degenerative diseases. Eur. J. Cancer Prev. 5:1997;307-312.
17. Jarosz M., Dzieniszewski J., Dabrowska-Ufniarz E., Wartonowicz M., Ziemlanski S., Reed P.I. Effects of high dose vitamin C treatment on Helicobacter pylori infection and total vitamin C concentration in gastric juice. Eur. J. Cancer Prev. 7:1998;449-454.
18. Austria R., Semenzato A., Bettero A. Stability of vitamin C derivatives in solution and topical formulation. J. Pharm. Biomed. Anal. 15:1997;795-801.
19. Miwa N., Yamazaki H., Nagaoka Y., Kagemaya K., Onoyama Y., Matsui-Yuasa I., Otani S., Morisawa S. Altered production of the active oxygen spices is involved in enhanced cytotoxic action of acylated derivatives of ascorbate to tumor cells. Biochim. Biophys. Acta. 972:1988;144-151.
20. Miwa N., Yamazaki H. Potentiated susceptibility of ascites tumor to acyl derivatives of ascorbate caused by balanced hydrophobicity in the molecule. Exp. Cell Biol. 54:1986;245-249.
21. Tabak M., Armon R., Neeman I. Cinnamon extracts' inhibitory effect on Helicobacter pylori. J. Ethnopharmacol. 67:1999;269-277.
22. Goodwin C.S., Armstrong J.A. Microbiological aspects of Helicobacter pylori (Campylobacter pylori). Eur. J. Clin. Microbiol. Infect. Dis. 9:1990;1-13.
23. Li C., Musich P.R., Ha T., Ferguson D.A., Patel N.R., Chi D.S., Thomas E. High prevalence of Helicobacter pylori in saliva demonstrated by novel PCR assay. J. Clin. Pathol. 48:1995;662-666.
24. Soltesz V., Zeeberg B., Wadström T. Optimal survival of Helicobacter pylori under various transport conditions. J. Clin. Microbiol. 30:1992;1453-1456.
25. Alberston N., Wenngren I., Sjostrom J.-E. Growth and survival of Helicobacter pylori in defined medium and susceptibility to Brij 78. J. Clin. Microbiol. 36:1998;1232-1235.
26. Drake I.M., Davies M.J., Mapstone N.P., Dixon M.F., Schorah C.J., White K.L.M., Chalmers D.M., Axon A.T.R. Ascorbic acid may protect against human gastric cancer by scavenging mucosal oxygen radicals. Carcinogenesis. 17:1996;559-562.
27. Ozaki, T., Matsuda, N., Yoshioka, T., Kado, T., Sugisaki, M. and Oka, H. (2001) Storage-stable skin-conditioning cosmetics containing water-soluble type I collagen and vitamin C derivatives. Jpn. Kokai Tokkyo Koho, 8 pp.
28. Rosenblat G., Graham M.F., Jonas A., Tarshis M., Schubert S.Y., Tabak M., Neeman I. Effect of ascorbic acid and its hydrophobic derivative palmitoyl ascorbate on the redox state of primary human fibroblasts. J. Med. Food. 4:2001;107-115.
29. Kageyama K., Onoyama Y., Otani S., Kimura M., Matsiu-Yuasa I., Nagao N., Miwa N. Promotive action of acylated ascorbate on cellular DNA synthesis and growth at low does in contrast to inhibitory action at high doses or upon combination with hyperthermia. J. Cancer Res. Clin. Oncol. 122:1996;41-44.
30. Matsui-Yauasa I., Otani S., Moriasawa K., Nonyama Y., Yamazaki H., Miwa N. Effect of acylated derivatives of ascorbic acid on ornitine decarboxylase induction in Ehrlich ascites tumor cells. Biochem. Int. 18:1989;623-629.
31. Rosenblat G., Perelman N., Katzir E., Gal-Or S., Jonas A., Nimni M.E., Sorgente N., Neeman I. Acylated ascorbate stimulates collagen synthesis in cultured human foreskin fibroblasts at lower doses than does ascorbic acid. Connect. Tissue Res. 37:1998;303-311.
32. Rosenblat G., Willey A., Zhu Y.-N., Jonas A., Diegelmann R.F., Neeman I., Graham M.F. Palmitoyl ascorbate: selective augmentation of procollagen mRNA expression compared with L-ascorbate in human intestinal smooth muscle cells. J. Cell Biochem. 73:1999;312-320.
33. Schmid E., Figala V., Ullrich V. Inhibition of NADPH-oxidase activity in human polymorphonuclear neutrophils by lipophilic ascorbic acid derivatives. Mol. Pharmacol. 45:1994;815-825.
34. Huang N., Liu F., Hu J., Zhang Q. ESR studies of the effect of vitamin C on biological membrane fluidity. Bopuxue Zazhi. 1:1984;415-419.
35. Navas P., Villalba J.M., Cordoba F. Ascorbate function at the plasma membrane. Biochim. Biophys. Acta. 1197:1994;1-13.
36. Dumas D., Muller S., Gouin F., Baros F., Viriot M.L., Stoltz J.F. Membrane fluidity and oxygen diffusion in cholesterol-enriched erythrocyte membrane. Arch. Biochem. Biophys. 341:1997;34-39.